GLENMARK GENERICS LIMITED

Patent Applications and Registrations

Patent applications and USPTO patent grants for GLENMARK GENERICS LIMITED.The latest application filed is for "process for the preparation of dipeptidylpeptidase inhibitors".

Company Profile

0.10.31

GLENMARK GENERICS LIMITED - Mumbai N/A IN
Glenmark Generics Ltd. - Mumbai IN
Glenmark Generics Ltd. - Mahwah NJ
Glenmark Generics Ltd. - Chakala Andheri East
Glenmark Generics Limited - Sawant Marg Chakala
Glenmark Generics LTD - Mumbai, Maharastra IN
GLENMARK GENERICS LTD - MUMBAI IN
GLENMARK GENERICS, LTD. - MUMBAI-400 IN
GLENMARK GENERICS LTD. - Andheri (East) Mumba IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Process for the preparation and purification of apixaban Grant 9,567,332 - Bhirud , et al. February 14, 2	2017-02-14
Process For The Preparation Of Dipeptidylpeptidase Inhibitors App 20150239887 - Singh; Sunil Kumar ; et al.	2015-08-27
Process For The Preparation Of Teneligliptin App 20150203484 - Kadam; Suresh Mahadev ; et al.	2015-07-23
Process for preparation of fingolimod Grant 9,056,813 - Gharpure , et al. June 16, 2	2015-06-16
Process For Preparation Of Substituted 3'-hydroazino-diphenyl-3-carboxylic Acid Compounds App 20150087845 - Upadhye; Bhargav Krishnaji ; et al.	2015-03-26
Process for the preparation of lasofoxifene tartrate Grant 8,937,188 - Khan , et al. January 20, 2	2015-01-20
Process For Preparation Of Fingolimod App 20150018578 - Gharpure; Milind ; et al.	2015-01-15
Stable Pharmaceutical Composition Of Saxagliptin App 20140072628 - Kaushik; Atul ; et al.	2014-03-13
Process for the preparation of strontium ranelate Grant 8,624,041 - Kumar , et al. January 7, 2	2014-01-07
Amorphous bupropion hydrobromide and preparation thereof Grant 8,450,376 - Sanganabhatla , et al. May 28, 2	2013-05-28
Process for the preparation of R-sitagliptin and its pharmaceutically acceptable salts thereof Grant 8,334,385 - Arjunan , et al. December 18, 2	2012-12-18
Palonosetron free base and process for its preparation Grant 8,304,544 - Khan , et al. November 6, 2	2012-11-06
Combination Composition Comprising Benzoyl Peroxide And Adapalene App 20120252897 - Mehta; Kamal ; et al.	2012-10-04
Processes for the Preparation of Indiplon and Intermediates Thereof App 20120028045 - Koilpillai; Joseph Prabahar ; et al.	2012-02-02
Process For The Purification Of Eslicarbazepine Acetate App 20120022047 - Koilpillai; Joseph Prabahar ; et al.	2012-01-26
Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof Grant 8,097,729 - Sawant , et al. January 17, 2	2012-01-17
Process For The Preparation Of Voriconazole App 20110312977 - D'Souza; Francis Paul ; et al.	2011-12-22
Process for the preparation of zofenopril and its pharmaceutically acceptable salts thereof App 20110281928 - Khan; Mubeen Ahmed ; et al.	2011-11-17
Process For The Preparation Of Esomeprazole Magnesium App 20110207779 - Prabahar; Koilpillai Joseph ; et al.	2011-08-25
Amorphous Bupropion Hydrobromide And Preparation Thereof App 20110105619 - Sanganabhatla; Shankar ; et al.	2011-05-05
Topical Composition Comprising Vitamin D Analogue And Corticosteroids App 20110053898 - Mehta; Kamal ; et al.	2011-03-03
Extended Release Pharmaceutical Composition Of Paliperidone App 20110052687 - Mehta; Kamal ; et al.	2011-03-03
Orally Disintegrating Tablets Of Zolmitriptan App 20110038928 - Mehta; Kamal ; et al.	2011-02-17
Process for the preparation of an optically active 5H-pyrrolo [3,4-B] pyrazine derivative Grant 7,863,273 - Pillai , et al. January 4, 2	2011-01-04
Process For The Preparation Of R-sitagliptin And Its Pharmaceutically Acceptable Salts Thereof App 20100317856 - ARJUNAN; SANKAR	2010-12-16
Amorphous Bazedoxifene Acetate And Preparation Thereof App 20100310870 - Sanganabhatla; Shankar ; et al.	2010-12-09
Palonosetron Free Base And Process For Its Preparation App 20100292267 - Khan; Mubeen ; et al.	2010-11-18
Solid Milnacipran And Process For The Preparation Of The Same App 20100274050 - KOILPILLAI; Joseph Prabahar ; et al.	2010-10-28
Process For The Preparation Of Esomeprazole Magnesium Dihydrate App 20100267959 - KOILPILLAI; Joseph Prabahar ; et al.	2010-10-21
Stable Fixed Dose Topical Formulation App 20100068284 - Dhuppad; Ulhas Rameshchandra ; et al.	2010-03-18
Pharmaceutical Composition Of Atovaquone App 20100028425 - Mehta; Kamal ; et al.	2010-02-04
Pharmaceutical Compositions Comprising Sumatriptan And Naproxen App 20100008986 - MEHTA; KAMAL ; et al.	2010-01-14
Tablet Compositions Of Amine Polymers App 20100008988 - MEHTA; KAMAL ; et al.	2010-01-14
Raloxifene Immediate Release Tablets App 20100003319 - Mehta; Pavak ; et al.	2010-01-07
Topical Gel Composition Comprising Azelaic Acid App 20100004338 - Sen; Nilendu ; et al.	2010-01-07
Pharmaceutical Composition Comprising Fluocinonide App 20090298803 - Sen; Nilendu ; et al.	2009-12-03
Esomeprazole Strontium Salt, Process For Its Preparation and Pharmaceutical Compositions Containing Same App 20090298884 - Bhirud; Shekhar Bhaskar ; et al.	2009-12-03
Topical Compositions Comprising Hydrocortisone Butyrate App 20090233892 - Sen; Nilendu ; et al.	2009-09-17
Pharmaceutical Compositions Comprising Simvastatin and Ezetimibe App 20090233898 - Mehta; Kamal ; et al.	2009-09-17
Pharmaceutical lotion comprising fluticasone propionate App 20090233891 - Sen; Nilendu ; et al.	2009-09-17
Process for the preparation of carboxamide compounds Grant 7,459,553 - Sivakumar , et al. December 2, 2	2008-12-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.